Big US pharma stocks rise as Street reacts to Trump’s tariff on drugs

President Trump announced new 100 percent import taxes on branded pharmaceuticals. These tariffs begin October 1. Companies building US manufacturing plants will be exempt. Major drugmakers like Merck and Lilly saw slight share increases. Analysts predict minimal impact on large firms. Smaller drugmakers might face vulnerability. Generic medicines remain unaffected by this new policy.

India’s options crackdown gives 150-year-old bourse surprise win

BSE is gaining ground in India’s derivatives market after SEBI’s crackdown reshaped weekly expiries. By shifting its contracts to Thursdays, the 150-year-old exchange has captured traders’ attention, challenging NSE’s long-held dominance. While liquidity hurdles remain, BSE’s rising turnover on expiry days signals a shift in market dynamics that could redefine competition in derivatives trading.

Jinkushal Industries IPO opens with healthy GMP buzz. Should you bid?

Jinkushal Industries, India’s leading non-OEM construction machinery exporter, is set to launch its Rs 116 crore IPO on September 25, with a price band of Rs 115-121 per share. The IPO has garnered significant grey market interest, and Anand Rathi Research recommends a ‘Subscribe – Long Term’ rating, citing the company’s strategic shift towards its HexL brand.

JD Cables IPO shares to list today; decent GMP keeps investors interested

JD Cables, a Howrah-based manufacturer, will launch on the BSE SME platform. The IPO saw strong investor interest, subscribing 127.8 times. The IPO price was finalized at Rs 152 per share. Grey market activity indicates a premium. Retail investors, QIBs, and NIIs showed significant demand. The company will use IPO proceeds for working capital and debt repayment.